The axonal microtubule-associated phosphoprotein tau interacts with neural plasma membrane (PM) components during neuronal development (Brandt, R., Lé ger, J., and Lee, G. . In polar neurons, the association of endogenous tau phosphoisoforms with the membrane cortex correlates with an enrichment in the axonal compartment. To test for a direct effect of AD-specific tau modifications in determining tau's interactions, a phosphomutant that simulates an AD-like hyperphosphorylation of tau was produced by site-directed mutagenesis of Ser/Thr residues to negatively charged amino acids (Glu). These mutations completely abolish tau's association with the membrane cortex; however, the construct retains its capability to bind to microtubules. The data suggest that a loss of tau's association with the membrane cortex as a result of phosphorylation at sites that are modified during disease contributes to somatodendritic tau accumulation, axonal microtubule disintegration, and neuronal death characteristic for AD.
The axonal tau proteins represent a family of closely related low molecular weight phosphoproteins that copolymerize with microtubules and that modulate the dynamic instability of tubulin assembly in cell-free reactions (1) (2) (3) (4) . When transfected in non-neuronal cells, tau induces microtubule polymerization and bundle formation, which is thought to result from the stabilization of cellular microtubules (5, 6) . In cultured neurons, tau is characteristically enriched in the distal axon, which contains the most dynamic and least stable microtubule population (7) (8) (9) . This is opposite to what would be expected for a microtubule-stabilizing protein and may suggest that tau has other or additional functions in neurons that distinguish it from other neuronal microtubule-associated proteins.
Previously, we have identified two types of tau interactions in neural cells: binding to microtubules and interaction with plasma membrane (PM) 1 components (10) . Microtubule binding requires the carboxyl-terminal half of the protein containing tau's microtubule-binding repeat domain, whereas tau's PM association is mediated by its amino-terminal domain, which protrudes from the microtubule surface when tau is bound to microtubules. Thus, these interactions are mediated by distinct domains, raising the possibility that tau functions as a linker protein between the microtubule system and axonal PM components. This idea is consistent with the previous finding that a growth cone-and membrane-associated protein requires tau for its localization (11) . In addition, tau close to the plasma membrane would be well positioned to participate in signal transduction mechanisms that may involve the recently identified interaction with Src family non-receptor tyrosine kinases (12) .
As a phosphoprotein, tau is a substrate for several kinases and phosphatases in vitro and in cells (for reviews, see Refs. 13 and 14) . The stoichiometry of tau phosphorylation is high in fetal brain and substantially decreased in the adult animal. However, tau isolated from patients with Alzheimer's disease (AD) has a high stoichiometry of phosphorylation that resembles tau modification during fetal development more than adult-specific phosphorylation. In AD, tau is redistributed from the axon toward the somatodendritic compartment, where it forms characteristic paired helical filaments (PHFs) (for a review, see Ref. 15) . It is thought that an increased phosphorylation state of tau ("hyperphosphorylation") represents an early and critical event during the development of tau pathology. In vitro, phosphorylation by several kinases, including protein kinase A and the neuronal kinase p110 microtubule affinityregulating kinase, greatly reduces tau's activity to promote microtubule assembly and increases dynamic instability (4, 16 -18) . In particular, phosphorylation of Ser 262 , which is located within tau's repeat domain (numbering refers to the adult human tau isoform containing 441 residues (19) ), abolishes tau's interaction with microtubules and may have a critical role in regulating tau's interaction with microtubules (20) . Several AD diagnostic antibodies such as AT-8, AT-180, and PHF-1 detect epitopes containing phosphorylated Ser-Pro or Thr-Pro motifs, which could point to an involvement of prolinedirected kinases, e.g. mitogen-activated protein kinase, glycogen synthase kinase-3␤, and Cdk5, in the disease process.
These kinases preferentially phosphorylate sites that flank the microtubule-binding domain of tau protein and have only a weak effect on the binding of tau to microtubules (21, 22) . It will be important to know how phosphorylation affects tau's non-microtubule interactions and whether proline-directed sites are involved.
To analyze the mechanism and potential regulation of tau's PM association, a fast and efficient method to separate PMassociated tau from cytosolic tau using microsphere separation of surface-biotinylated cells was developed. We demonstrate that tau phosphoisoforms are differentially distributed in the PM and cytosolic fractions using phosphorylation-sensitive tau antibodies that are directed against sites modified in PHFs. In addition, we show that tau's PM association requires an intact membrane cortex and is regulated by phosphorylation. In polar neurons, the association of endogenous tau phosphoisoforms with the membrane cortex correlates with an enrichment in the axonal compartment. Phosphomutants that simulate a PHFlike hyperphosphorylation of tau in regions that flank the microtubule-binding domain are defective in their association with the membrane cortex, but can still bind to microtubules.
EXPERIMENTAL PROCEDURES
Materials-Chemicals were purchased from Sigma (Deisenhofen, Germany), cell culture media and supplements from Life Technologies, Inc., tissue culture flasks and dishes from Nunc (Roskilde, Denmark), and restriction enzymes and T4 DNA ligase from MBI Fermentas (St. Leon-Rot, Germany), unless stated otherwise. Tubulin was isolated from bovine brain by two assembly-disassembly cycles and phosphocellulose chromatography as described previously (23) .
Cell Culture, Transfection, and Immunocytochemistry-PC12 cells were cultured in serum/DMEM (DMEM supplemented with 10% fetal bovine serum, 5% horse serum, 292 g/ml glutamine, 50 units/ml penicillin, and 50 g/ml streptomycin) and transfected using Lipofectin as described previously (10) . For generation of stable lines, cells were selected with Geneticin, and individual clones were isolated as described previously (10) . Stable lines were cultured in serum/DMEM supplemented with 250 g/ml Geneticin. For immunocytochemistry, PC12 cells were grown on polylysine-coated glass coverslips. NT2 cells were grown, differentiated for 5 weeks with retinoic acid, replated, and cultured for another 2 weeks in the presence of mitotic inhibitors to yield terminally differentiated neurons (NT2-N cells) as described previously (24) . For immunocytochemistry, the neurons were plated at 2000 cells/cm 2 onto Matrigel (Becton Dickinson, Bedford, MA)-coated coverslips and cultured for another 3 days in serum-containing medium. Following this treatment, almost all neurons had established polarity as judged from axon-specific tau staining.
Cells were fixed with 4% (w/v) paraformaldehyde in PBS (10 mM phosphate buffer, pH 7.4, 2.7 mM KCl, and 137 mM NaCl) containing 4% (w/v) sucrose for 20 min at room temperature. After washing with PBS, cells were incubated with 0.1 M glycine in PBS for 20 min and permeabilized for 5 min in 0.2% (v/v) Triton X-100 in PBS. For detergent extraction, a combined Nonidet P-40 extraction-fixation procedure as described previously (6) was used. Staining was performed essentially as described earlier (6) in PBS containing 1% (w/v) bovine serum albumin using monoclonal mouse antibodies against tau (Tau-1 (25) and PHF-1 (26)) and FLAG (M5, Eastman Kodak Co.), monoclonal rat antibody against tubulin (YL1/2 (27)), and fluorescein isothiocyanatecoupled donkey anti-rat and Cy3-coupled donkey anti-mouse antibodies (all secondary antibodies from Dianova, Hamburg, Germany). For total protein staining, cells were washed after the secondary antibody reaction five times for 2 min each with PBS, incubated for 15 min with 10 g/ml 5-([4,6-dichlorotriazin-2-yl]amino)fluorescein (DTAF), and washed five times for 2 min each with PBS. Coverslips were mounted in anti-fade medium as described previously (10) .
Microsphere Separation of Neural Plasma Membranes-Tau-transfected PC12 cells were grown to ϳ80% confluency on a collagen-coated 10-cm tissue culture dish; washed once with prewarmed PBS; incubated with prewarmed PBS containing 2 mM MgCl 2 and 0.5 mM CaCl 2 for 10 min at room temperature; transferred to 4°C, and incubated for another 10 min. Cells were surface-labeled with 0.1 mg/ml sulfosuccinimidyl 2-(biotinamido)ethyl-1,3Ј-dithiopropionate (Pierce) in PBS containing 2 mM MgCl 2 and 0.5 mM CaCl 2 for 30 min; quenched for 20 min with PBS containing 2 mM MgCl 2 , 0.5 mM CaCl 2 , and 50 mM glycine; and washed once with 0.25 M sucrose, all at 4°C. Streptavidin-coupled microspheres (ϳ1 m in diameter) were washed once with PBS and twice with 0.25 M sucrose using a magnetic bead attractor (Stratagene, Heidelberg, Germany) and added onto the cells, and incubation was continued for 1 h at 4°C. Cells were washed with 0.25 M sucrose, and 2.4 ml of separation buffer (0.25 M sucrose containing 1 mM ATP, 1 mM MgCl 2 , 1 mM EGTA, and protease and phosphatase inhibitors (1 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, 10 g/ml pepstatin, 1 mM sodium pyrophosphate, 1 mM sodium orthovanadate, and 20 mM NaF)) were added on ice. Then, the cells were scraped off, distributed into 1.5-ml Sarstedt tubes, and quick-frozen in liquid nitrogen. After thawing on ice, tubes were transferred into a magnetic bead attractor, and the unbound fraction (cytosol/crude organelles) was removed. The bound fraction (PM) was washed three times with 500 l of separation buffer/tube. The S-S bridge of the biotin derivative was cleaved by incubation with 750 l of separation buffer containing 0.1 M 2-mercaptoethanol. The suspension was pressed five times through a 27-gauge needle, incubated for 30 min at 4°C with vortexing, and separated using the bead attractor. The cleavage procedure was repeated once; the supernatants were pooled; and the PM was collected by ultracentrifugation (100,000 ϫ g, 1 h, 4°C). For comparative analysis, the unbound fraction was separated by ultracentrifugation (100,000 ϫ g, 1 h, 4°C) into a crude organelle pellet and the cytosol. The pellet fractions were resuspended in 100 l of separation buffer. The cytosolic fraction was precipitated with trichloroacetic acid/deoxycholate as described previously (28) . NT2-N cells were cultured on collagen-coated 6-cm tissue culture dishes, and all buffer volumes were adjusted according to the smaller area of the dishes.
For separation under actin-stabilizing conditions, cells were cultured for 1 h in serum/DMEM containing 0.1 M jasplakinolide (Molecular Probes, Inc., Leiden, Netherlands). The wash at room temperature was performed in the presence of 0.1 M jasplakinolide, and all subsequent steps in separation buffer contained 5 M phalloidin (AppliChem, Darmstadt, Germany).
For separation under actin-depolymerizing conditions, cells were cultured for 1 h in serum/DMEM containing 0.35 g/ml latrunculin B (Calbiochem-Novabiochem GmbH, Bad Soden, Germany). The wash at room temperature was performed in the presence of 0.35 g/ml latrunculin B, and all subsequent steps in separation buffer contained 0.35 g/ml latrunculin B in the absence of ATP, MgCl 2 , and EGTA.
For separation after phosphatase treatment, cells were cultured for 1 h in serum/DMEM containing 10 or 100 nM okadaic acid. The wash at room temperature was performed in the presence of 10 or 100 nM okadaic acid, and all subsequent steps were carried out under standard conditions.
Electron Microscopy-Isolated plasma membranes were fixed for 3 h with 2% (v/v) paraformaldehyde and 2.5% (v/v) glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4, and then post-fixed for 1 h with 1% (w/v) OsO 4 (Herth, Mü nchen, Germany) and 1.5% (w/v) K 3 (Fe(CN) 6 ) (Merck, Darmstadt) in 0.1 M sodium cacodylate buffer, pH 7.4. The membranes were washed with water, en bloc stained for 1 h with 1% (w/v) uranyl acetate (Merck), washed with water, and then dehydrated with graded ethanol followed by propylene oxide. Membranes were embedded in 1,2,3-propanetriol glycidyl ether (Serva, Heidelberg) by conventional methods, sectioned, and contrasted consecutively with uranyl acetate and lead citrate. Electron microscopy was performed on a Zeiss 10CR electron microscope.
Co-sedimentation Assays-For co-sedimentation assays, Taxol-stabilized microtubules were prepared by polymerizing 30 M purified tubulin in BRB80 (80 mM Pipes/KOH, pH 6.8, 1 mM CaCl 2 , and 1 mM EGTA) containing 1 mM GTP by stepwise addition of 0.01 volume of 10 M, 100 M, and 1 mM Taxol for 5 min at 37°C each. Tau-transfected PC12 cells were collected by centrifugation and washed once with PBS. Rat tau (2 ϫ 10 6 ) or human tau (5 ϫ 10 6 ) cells were suspended in 50 l of PBS containing protease and phosphatase inhibitors, quick-frozen in liquid nitrogen, thawed on ice, and centrifuged at 100,000 ϫ g for 1 h at 4°C. The supernatant was adjusted to 1 mM GTP and 10 M Taxol in a total volume of 70 l with BRB80, prewarmed at 37°C, and divided. One-half was mixed with 15 l of Taxol-stabilized microtubules, and the other half was mixed with 15 l of BRB80 containing 10 M Taxol. After incubation for 10 min at 37°C, the mixtures were centrifuged through 100 l of 30% (w/v) sucrose cushions in BRB80 containing 1 mM GTP and 10 M Taxol at 100,000 ϫ g for 1 h at 20°C. The pellets were resuspended in 150 l of BRB80. 1% (v/v) (anti-tubulin antibody) or 89% (v/v) (anti-tau antibodies) of each fraction was separated by SDS-polyacrylamide gel electrophoresis with 10% acrylamide and analyzed by immunoblotting.
Immunoblot and Dot-blot Analyses-SDS-polyacrylamide gel electro-phoresis and immunoblotting were performed as described previously (23) The distribution of label in cellular compartments (axon and somatodendritic compartment) or in individual processes of human model neurons was determined as described previously (30) . For each condition, 10 representative neurons with no contact with other cells were evaluated, and the means Ϯ S.E. were calculated. To compare processes with different lengths, fluorescence intensities were normalized to a maximum total fluorescence intensity of 1.0 of the respective label and plotted against the relative position in the axon (maximum length set as 1.0).
Construction and Expression of Tau Mutants-Eukaryotic expression plasmids for human tau were constructed in fpRc/CMV as described previously (31) . The vector fpRc/CMV had been modified from pRc/CMV (Invitrogen, San Diego, CA) to express proteins with the sequence MDKDDDDK (FLAG) (32, 33) , and Ser 422 were mutated to GAA (glutamate) by polymerase chain reaction or site-directed mutagenesis (Muta-Gen TM phagemid in vitro mutagenesis kit, Bio-Rad). Constructs were verified by dideoxy sequencing using T7 sequenase (Amersham Pharmacia Biotech).
Other Methods-Protein concentrations were determined by the method of Bradford (34) using bovine serum albumin as a standard. Alkaline phosphodiesterase-1 assays were essentially performed as described previously (35) . 25-l samples were diluted with 25 l of 0.25 M sucrose in a chilled 1.5-ml Sarstedt tube. 200 l of reaction mixture (2.5 mM sodium thymidine 5Ј-monophosphate p-nitrophenyl ester and 250 mM Tris-HCl, pH 9.0) were added, vortexed, and incubated at 37°C. As soon as a color reaction was observed (from 2 h to overnight), 500 l of 0.5 M glycine and 0.5 M sodium carbonate were added, and the absorbance was measured against a blank (50 l of 0.25 M sucrose instead of sample) at 410 nm.
Lactate dehydrogenase assays were essentially performed as described previously (35) . The samples were adjusted with 0.25 M sucrose to 100 l. 900 l of reaction mixture (0.2 mM ␤-NADH, 1 mM sodium pyruvate, and 0.1% (v/v) Triton X-100 in 0.2 M Tris-HCl, pH 7.3) were added, vortexed, and incubated at room temperature. Lactate dehydrogenase activity was read as a decrease in absorption at 340 nm measured against a blank (100 l of 0.25 M sucrose instead of sample). Prior to the assay, the cytosolic fraction was concentrated by dialysis against 0.2 M imidazole-HCl, pH 7.2, and lyophilization.
RESULTS

Isolation of Plasma Membrane-associated Tau by Micro-
sphere Separation of Surface-biotinylated Cells-In PC12 cells stably transfected with adult rat tau cDNA, tau was clearly enriched at the cellular periphery as judged by laser scanning microscopy of cells that had been processed for immunocytochemistry (Fig. 1A) . The distribution of tau did not reflect the total protein distribution in the cells, which was, as determined from staining with the general protein stain DTAF, more concentrated at the center of the cell. No tau staining was observed in unpermeabilized cells, indicating that tau interacts with the cytosolic face of integral PM components or components of the membrane cortex.
To analyze the mechanism and potential regulation of tau's association with the plasma membrane, a method to isolate a PM fraction including the submembranous cortex from cultured cells was developed. The method is based on microsphere separation of surface-biotinylated cells and yielded three fractions: a PM fraction that was highly enriched in plasma membrane components, a crude organelle fraction that contained all types of membranous organelles together with residual plasma membrane that did not bind to the beads, and a cytosolic fraction representing the supernatant of a high speed centrifugation of the unbound material (Fig. 1B) . The PM fraction contained ϳ60% of high mannose-type glycoproteins frequently found in plasma membranes (36) as indicated by a concanavalin A dot-blot (Fig. 1C) . About 20% of the total protein and ϳ60% of the specific activity of the PM enzyme alkaline phosphodiesterase-1 were present in this fraction (Table I) . Immunoblot analysis showed the presence of the transferrin receptor that is abundantly expressed on the cell surface of many cultured cell lines (37) and actin (25-40% for independent isolations), as would be expected for a fraction containing plasma membranes and a submembranous cortex (Fig. 1C) . Tubulin, which behaves as a cytosolic protein under the conditions used for the fractionation (isolation at 4°C), was almost completely absent from the PM fraction (Ͻ2% of total tubulin), indicating a very low degree of contamination with cytosolic proteins. In agreement with the latter result, the specific activity of the cytosolic enzyme lactate dehydrogenase was very low in the PM fraction (ϳ1%) ( Table I ). Electron microscopy of the isolated PM fraction revealed the presence of a large number of apparently empty vesicles with an irregular shape and a diameter ranging between 50 and 700 nm, probably representing plasma membrane vesicles (Fig. 1D) .
About 20% of tau was present in the PM fraction as judged by immunoreactivity against the epitope tag (FLAG) or an antibody recognizing all tau isoforms (Tau-5) (Fig. 1C) . In this fraction, tau could also be detected with the antibody Tau-1, which recognizes a dephosphorylated epitope in the middle of the protein (Ser 199 ). In contrast, immunoreactivity against the antibody PHF-1, which recognizes a phosphorylated epitope at Ser 396 /Ser 404 , was almost completely absent from the PM fraction (Ͻ4%). The immunoblot data are in agreement with results from laser scanning microscopy analysis showing peripheral enrichment with Tau-1, but not with the PHF-1 antibody (data not shown). To test whether the different tau phosphoisoforms also have distinguishable interactions with microtubules, co-sedimentation assays of cellular lysates with Taxolstabilized microtubules were performed. Both Tau-1-and PHF-1-immunoreactive tau isoforms completely co-sedimented with the microtubule polymer, indicating their ability to effectively interact with microtubules ( Fig. 2A) . In agreement, both populations similarly associated with the microtubule cytoskeleton as judged by immunofluorescence from detergent-extracted cells (Fig. 2B) .
Tau's Association with the Plasma Membrane Requires an Intact Membrane Cortex and Is Regulated by Phosphorylation-To determine whether tau directly interacts with integral plasma membrane components or requires the cortical cytoskeleton, PM and cytosolic fractions were prepared by microsphere separation under actin-stabilizing conditions (cul-ture with jasplakinolide and microsphere separation with phalloidin, both of which bind to F-actin and induce actin polymerization (38)) or actin-depolymerizing conditions (culture and separation with latrunculin B, which disrupts microfilament organization (39)) and were compared by immunoblotting. Under actin-stabilizing conditions, actin was almost completely absent from the cytosol and highly enriched in the PM fraction (Fig. 3A) . Under actin-depolymerizing conditions, the actin distribution was reverse, and almost no actin was found in the PM fraction. With either condition, the distribution of tubulin was unaffected, indicating that the drugs selectively influence the state of the actin cortex. Tau was present in the PM fraction under actin-stabilizing conditions, but was completely absent under actin-depolymerizing conditions, indicating that tau's association with the plasma membrane requires an intact cortical cytoskeleton.
To determine a potential role of individual phosphorylation sites in tau's membrane association, several phosphorylationdependent antibodies were tested in microsphere-separated cells. Unfortunately 
c Mean Ϯ range (n ϭ 2).
FIG. 1. Isolation of plasma membrane-associated tau by microsphere separation of surface-biotinylated cells.
A, laser scanning micrograph showing the distribution of total protein (DTAF) and total tau (FLAG) in a single optical section of a PC12 cell stably transfected with rat tau; B, schematic of the microsphere isolation protocol; C, concanavalin A (ConA) dot blot and immunoblot of the distribution of cytoskeletal and membrane marker proteins and tau phosphoisoforms in the cytosol (cyt), the crude organelles (org), and the plasma membrane fraction (pm); D, electron micrograph of the isolated plasma membrane fraction. PC12 cells stably transfected with adult rat tau cDNA were fixed, permeabilized, and stained as described under "Experimental Procedures." Laser scanning microscopy was performed at a single optical section halfway through the cellular height. DTAF, a monoclonal mouse antibody against the FLAG epitope (M5), and a Cy3-coupled anti-mouse secondary antibody were used for staining procedures. Plasma membrane preparation, dot-blot and immunoblot analyses, and electron microscopy were performed as described under "Experimental Procedures" with PC12 cells stably expressing rat tau. construct. Therefore, PC12 lines stably transfected with fetal human tau cDNA were produced and analyzed. Also in these cells, tau could be detected in the PM fraction after microsphere separation, indicating that no adult-specific sequences are required and that tau also interacts with PM components in a heterologous system of human tau in rat cells (Fig. 3B, no  drug) . The dephosphorylated tau isoform appeared to be enriched in the PM fraction. About 50% of the dephosphorylated epitope (Ser 199 ) recognized by the Tau-1 antibody was found in the PM fraction, whereas only 25% of total tau was PM-associated. All tau phosphoisoforms tested (PHF-1-, AT-8-, and AT-180-immunoreactive tau) were exclusively cytosolic and absent from the PM fraction.
To determine whether tau's interaction with the membrane cortex is regulated by phosphorylation, human tau-transfected cells were treated with the phosphatase inhibitor okadaic acid (40, 41) to increase the cellular phosphorylation state prior to microsphere separation. Incubation with 10 and 100 nM okadaic acid resulted in the complete loss of tau from the plasma membrane fraction as detected with the Tau-5 and Tau-1 antibodies (Fig. 3B) . No change in the distribution of actin was observed, indicating that okadaic acid does not disassemble the actin cortex. To determine whether okadaic acid affects the composition of tau phosphoisoforms, cells were treated with different concentrations of okadaic acid, and the lysates were probed with phosphorylation-sensitive tau antibodies. Under our conditions, no significant change in the ratio of the Tau-1-, PHF-1-, AT-8-, or AT-180-immunoreactive tau isoform compared with total tau was observed (data not shown). This may indicate that tau phosphorylation at sites other than those detected by the antibodies used in this study is involved in regulating tau's association with the membrane cortex. Alternatively, phosphorylation of another component in the membrane cortex may regulate tau binding.
Axonal Binding of Endogenous Tau Correlates with Plasma Membrane Association in Human Model
Neurons-Tau binds to the distal axon early during the development of neuronal polarity in cultured hippocampal neurons (8, 9) . Axonal tau binding was also observed in a culture model for human central nervous system neurons, NT2-N cells, which represent terminally differentiated neurons (24) . This indicates that the model neurons exhibit a polarized cytoarchitecture and localize tau in a way similar to primary neurons. It is possible that tau binding to the membrane cortex is responsible for this localization since distal axonal tau binding requires intact microfilaments (8) . In this case, only tau isoforms that interact with the membrane cortex would be expected to exhibit an axonal enrichment, whereas non-PM-binding isoforms should be distributed more uniformly in the neurons.
To determine the distribution of tau phosphoisoforms in NT2-N cells, the neurons were processed for semiquantitative immunofluorescence analysis after a combined extraction-fixation protocol known to preserve tau's interactions in neurons (8) . Axonal tau enrichment was observed after staining with a polyclonal antibody recognizing all tau isoforms (data not shown) and with the Tau-1 antibody (Fig. 4, A and B) . The axonal tau distribution exhibited a proximodistal gradient, with Tau-1-immunoreactive tau being most concentrated in the distal axon (Fig. 4A, upper left panel) . In contrast, no distal axonal enrichment of PHF-1-immunoreactive tau was observed (Fig. 4A, lower left panel) . To quantitate the amount of tau and microtubules relative to their positions in the axon, the distribution of label was quantified in consecutive 10-m segments of the axon. Linear regression analysis confirmed a significant increase in tau toward the distal axon when stained with the Tau-1 antibody (p Ͻ 0.01, n ϭ 10), whereas no significant increase in PHF-1-immunoreactive tau or tubulin was observed (p Ͼ 0.5, n ϭ 10). More than 50% of axonal tau was present in the distal third of the axon as determined using the Tau-1 antibody (Fig. 4B) . In contrast, PHF-1-immunoreactive tau was uniformly distributed in the axons.
To analyze whether endogenous tau in model neurons associates with the plasma membrane as was observed for transfected tau in the PC12 system, microsphere separation of surface-biotinylated NT2-N cells was performed. With these neurons, an effective isolation of the plasma membrane fraction was also achieved as indicated by the enrichment of the human transferrin receptor (hTfR), the presence of actin, and the absence of tubulin as a cytosolic marker ( Fig. 4C ; compare with Fig. 1C) . A substantial fraction of Tau-1 immunoreactivity was present in the PM fraction, indicating that tau associates with the neuronal membrane cortex similarly to transfected tau in PC12 cells. Almost no PHF-1-immunoreactive tau was present in the PM fraction of the neurons, indicating that endogenous tau phosphoisoforms differentially associate with the plasma membrane in neurons similar to the PC12 model. The data demonstrate that the axonal binding of tau phosphoisoforms correlates with tau's ability to associate with the plasma membrane, which may suggest that tau's interaction with the membrane cortex contributes to tau's enrichment in the distal axon during neuronal development.
Simulation of PHF-like Tau Phosphorylation Prevents Tau's Interaction with the Membrane Cortex-
The distribution of tau isoforms in the PM fraction and the loss of tau from the PM after okadaic acid treatment suggest a regulatory role of tau phosphorylation in determining tau's PM association. Since tau from AD patients is hyperphosphorylated, a phosphorylationinduced change in tau's PM association may contribute to the   FIG. 3. Effect of F-actin-stabilizing and F-actin-depolymerizing conditions and okadaic acid on the association of tau with isolated plasma membranes. A, distribution of actin, tubulin, and tau in the cytosolic (cyt) and plasma membrane (pm) fractions after microsphere separation under conditions that stabilize (left panels) or depolymerize (right panels) F-actin; B, effect of pretreatment of the cells with okadaic acid on the distribution of actin, tubulin, and tau after microsphere separation. Drug treatments and microsphere separations were performed as described under "Experimental Procedures" with PC12 cells stably expressing rat tau (A) or fetal human tau (B). Immunoblot analyses were performed as described in the legend of Fig. 1. pathologic processes. To functionally assay the effect of a disease-type tau hyperphosphorylation, we produced a tau phosphomutant that simulates phosphorylation of serine/threonine residues by site-directed mutagenesis to negatively charged amino acids. In other systems, aspartate and glutamate mutations have successfully mimicked phosphorylation events (42-44), and we have previously shown that aspartate mutations simulate the phosphorylation of single protein kinase A sites on tau structure and function (31) . Interestingly, in some systems, glutamate was more effective than aspartate in mimicking phosphorylation, suggesting an important role of the length of the side chain that delivers the charge (43). We therefore decided to change 10 serine/threonine residues to glutamate at positions that have previously been identified as major targets for phosphorylation in tau isolated from paired helical filaments (45) to mimic a PHF-like tau hyperphosphorylation (Fig. 5A) .
To test the effect of the mutations on tau's association with the plasma membrane, PC12 cells were stably transfected with human wild-type tau and the PHF-like tau phosphomutant.
Microsphere separation was performed after surface biotinylation of the cells as described above, and the cytosolic and PM fractions were compared by immunoblot analysis. A substantial fraction of wild-type tau could be isolated with the PM fraction as analyzed using the phosphorylation-insensitive antibody Tau-5 (Fig. 5B) . In contrast, no tau was present in the PM fraction in cells expressing the PHF-like tau phosphomutant.
To test, whether the phosphomutant was still able to interact with microtubules, co-sedimentation assays of cellular homogenates from stably transfected PC12 cells with Taxol-stabilized microtubules were performed. Both wild-type tau and the PHF-like phosphomutant similarly co-sedimented with the microtubule polymer (Fig. 5C ), indicating that the phosphomutant effectively interacts with microtubules despite its loss of binding to the membrane cortex. Interestingly, also the PHF-1-, AT-8-, and AT-180-immunoreactive wild-type tau isoforms co-sedimented with the microtubule polymer, indicating the ability to interact with microtubules. The phosphomutant was not reactive against these antibodies, indicating that the mutations did not simulate the phosphorylated epitope recognized by PHF-1, AT-8, and AT-180 (data not shown). The data suggest that tau's activity to bind to microtubules and its interaction with the membrane cortex are differentially affected by phosphorylation. In particular, phosphorylation at sites that are modified in tau isolated from PHFs and that flank tau's microtubule-binding domain may selectively inhibit tau's association with the membrane cortex without affecting its microtubule interaction. DISCUSSION Previously, we have identified two types of interactions of the microtubule-associated protein tau in neural cells: binding to microtubules and interaction with the cellular periphery (10) . To characterize tau's peripheral association, a novel method to isolate plasma membrane-associated tau based on microsphere separation of surface-biotinylated cells was developed. We demonstrate that the PM fraction that was isolated using this procedure is highly enriched in plasma membrane markers, is almost completely devoid of cytosolic protein, and contains variable amounts of actin indicative of the presence of the membrane cortex. The isolation can be performed under various conditions to manipulate the status of the cell, including a change in the phosphorylation state or a disruption of the cortical actin. Using this method, we demonstrate that tau associates with the membrane cortex of PC12 cells and human model neurons in a phosphorylation-dependent manner.
It has previously been shown that tau not only binds to microtubules, but also interacts with actin filaments in vitro (46, 47) , an activity that could also be involved in tau's association with the membrane cortex. However, it is unlikely that a direct interaction with actin is involved since we never observed a colocalization of tau with actin-rich structures in filopodia of PC12 cells or developing neurons. In addition, actin binding requires the repeat domain, which is also involved in microtubule interaction (48, 49) , whereas tau binding to the membrane cortex was also observed with a carboxyl-terminally deleted tau fragment lacking the repeats (10) . Until now, we NT2-N cells) . A, double staining for tau (left panels) and tubulin (right panels) of detergent-extracted neurons using phosphorylation-sensitive antibodies (Tau-1 and PHF-1); B, quantitation of the distribution of tau in extracted neurons (upper panel) and axons (lower panel) using phosphorylation-sensitive tau antibodies (Tau-1 and PHF-1); C, microsphere separation and immunoblot analysis of the distribution of membrane marker (hTfR) and cytoskeletal (actin and tubulin) proteins and tau phosphoisoforms (Tau-1 and PHF-1) in the cytosolic (cyt) and plasma membrane (pm) fractions. Immunocytochemistry, quantitation of fluorescence distribution, microsphere separation, and immunoblot analysis were performed as described under "Experimental Procedures." Neurons were processed using a combined fixation-extraction protocol and double-stained with monoclonal Tau-1 or PHF-1 antibody, anti-tubulin rat antibody (YL1/2), and Cy3-coupled anti-mouse and fluorescein isothiocyanatecoupled anti-rat secondary antibodies. Tau and tubulin distributions in axons of 10 double-stained neurons were quantitated. Means Ϯ S.D. are shown. Individual axon lengths ranged from 50 to 400 m with a mean of 188 m. The microsphere separation was performed under standard conditions starting from one 10-cm dish (hTfR, actin, and tubulin) or 14 6-cm tissue culture dishes (tau) of terminally differentiated NT2-N cells. For immunoblot analysis, 1% (v/v) (tubulin and actin), 30% (v/v) (hTfR), and 100% (v/v) (tau) of each fraction were separated by SDSpolyacrylamide gel electrophoresis with 10% acrylamide. Scale bars ϭ 10 m.
were not able to reconstitute tau's association with isolated membranes in vitro, which may indicate that tau's association with the membrane cortex involves a complex and delicate interaction of several components with the participation of actin filaments.
A substantial fraction of total tau and Tau ), and PHF-1 (Ser 396 /Ser 404 ) was not present in isolated PM fractions. All these antibodies detect epitopes containing phosphorylated Ser-Pro or Thr-Pro motifs, which could point to an involvement of proline-directed kinases, e.g. mitogen-associated protein kinase, glycogen synthase kinase-3beta and Cdk5, in determining tau's interaction with the membrane cortex. Mitogen-associated protein kinase and glycogen synthase kinase-3beta are known to phosphorylate sites that flank the microtubule-binding domain of tau protein and have only a weak effect on the binding of tau to microtubules (21, 22) . In agreement, PHF-1-immunoreactive tau isoforms effectively bound to microtubules in co-sedimentation assays, suggesting a role of phosphorylation at prolinedirected sites in selectively regulating tau's PM interaction without affecting its activity on microtubules. On the other hand, it is known that non-proline-directed phosphorylation at certain sites within the repeat domain (e.g. Ser 262 , which is phosphorylated by the kinase p110 microtubule affinity-regulating kinase) and at flanking regions (e.g. Ser 214 , which is phosphorylated by protein kinase A) greatly affects tau's microtubule interaction and detaches tau from microtubules (20, 21) . It will be interesting to determine whether phosphorylation at Ser 262 or Ser 214 also inhibits tau's association with the membrane cortex or whether phosphorylation at these sites acts as a selective switch in regulating tau's interaction with the microtubule surface.
In brain, tau is specifically enriched in the nerve axon, and tau's intracellular interactions may contribute to its localization and axonal function. Using terminally differentiated polar human model neurons (NT2-N cells) , we show that Tau-1-immunoreactive tau is enriched in the distal axon relative to the distribution of microtubules. In contrast, no distal enrichment of the PHF-1-immunoreactive tau subpopulation was detected. The difference in axonal localization correlates with the distribution of the tau phosphoisoforms in isolated PMs: Tau-1-immunoreactive tau, which showed a distal axonal enrichment, is present in the PM in NT2-N neurons. In contrast, PHF-1-immunoreactive tau, which is not distally enriched, also is not associated with the neuronal PM. The results are consistent with the idea that tau's PM association has a role in determining tau's neuronal localization. A spatial control of tau phosphorylation at proline-directed sites flanking tau's microtubule-binding domain may regulate tau's interaction at the distal axonal shaft independent from its binding to microtubules. The function of tau in the distal axon and the molecular components that are involved in tau's PM binding are still unclear. We have previously shown that tau binding precedes the accumulation of microtubules at the axonal tip during axonal elongation, suggesting a role for tau in locally regulating microtubule assembly at this location and connecting microtubules with the axonal membrane cortex (30) . Interestingly, in tau knock-out mice, morphological abnormalities were found in small caliber axons (50) . Since these axons are characterized by a high inner surface/volume ratio, this may point toward a function of tau in selectively stabilizing the axonal cytoskeleton by cross-linking the microtubules with components of the membrane cortex. Recently, it has also been shown that tau interacts with Src family non-receptor tyrosine kinases as membrane-associated components through a prolinerich sequence in tau's amino terminus (12) . However, the potential interaction site (amino acids 233-236) is not contained in tau deletion fragments that localize to the cellular periphery (10), arguing against an involvement of this interaction in determining tau's PM localization. On the other hand, tau close to the axonal membrane may be well positioned to play a role in signal transduction mechanisms at the distal axon involving membrane-associated kinases.
Tau phosphorylated at sites recognized by several AD diagnostic antibodies such as AT-8, AT-180, and PHF-1 was not present in isolated PM fractions, suggesting that specific phosphorylation events during the disease may affect tau's association with the membrane cortex. To test this hypothesis, an "AD-like" hyperphosphorylation of tau was simulated by mutating 10 major phosphorylation sites that had been identified A, schematic of the tau constructs. The major phosphorylation sites in tau isolated from PHFs were mutated from Ser/Thr to Glu to simulate an AD-like tau hyperphosphorylation. The repeat domain is indicated by the white boxes. B, distribution of actin, tubulin, and tau in the cytosolic (cyt) and plasma membrane (pm) fractions after microsphere separation of PC12 cells stably transfected with fetal human tau (left panels) or the PHF-like tau phosphomutant (right panels). C, Western blots of supernatant (S) and pellet (P) fractions after ultracentrifugation of cellular lysates from PC12 cells stably transfected with fetal human tau (left panels) or the PHF-like tau phosphomutant (right panels) with Taxol-stabilized microtubules (MTs). The preparation of the constructs, microsphere separation, and co-sedimentation assays were performed as described under "Experimental Procedures." Immunoblot analyses were performed as described in the legend of Fig. 1 . The arrowhead in C shows the position of the AT-180-reactive tau band; an unspecific signal that was also observed in lysates with the AT-180-negative phosphomutant is indicated by the asterisk. wt, wild-type. in paired helical filaments from patients with AD from Ser/Thr to negatively charged amino acids (glutamate). Indeed, the PHF-like tau phosphomutant lost its activity to associate with the membrane cortex, whereas it was still able to bind to microtubules. Since the histopathology of AD is characterized by a somatodendritic accumulation of the axonal microtubuleassociated protein tau and an increased immunoreactivity of tau against phosphorylation-dependent antibodies, a loss of tau's cortical interaction as a result of phosphorylation at sites modified in PHFs or other components of the membrane cortex may trigger tau's redistribution from the axon to the somatodendritic compartment. This cellular mislocalization of tau may contribute to the disintegration of the axonal cytoskeleton, the aggregation of tau into filaments and tangles, and the death of the neurons, all of which have been found in patients with AD.
